Bloom Diagnostics
Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time.
Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time.
Bloom Diagnostics is a Switzerland-based startup founded in 2018, operating in the Health Care and Health and Wellness industries. The company's slogan, "Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time," underscores its innovative approach. Bloom's proprietary technology enables the quantitative measurement of health markers from a single drop of blood, providing personalized health insights within minutes. Currently, Bloom offers tests for ferritin, thyroid, inflammation, and kidney health, with plans to expand its portfolio and technologies. In December 2022, Bloom Diagnostics secured a $1.20M Series B investment from Astor Perkins, signifying confidence in the company's vision and potential. This investment is a testament to the value perceived in Bloom's innovative technology and its potential to revolutionize personalized health diagnostics. As Bloom continues to develop and expand its offerings, the recent investment is expected to further propel its growth within the health tech sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $1.20M | 1 |
|
20 Dec 2022 |
| Series B | $6.00M | - | 20 Nov 2021 | |
| Series B | €10.00M | 3 |
|
31 May 2020 |
| Series A | €5.00M | 2 |
|
31 May 2019 |
| Seed Round | €3.70M | - | 31 May 2018 |
We care about your data, and we'd love to use cookies make your experience better.
